Melinta Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MLNTQ and buy or sell other stocks, ETFs, and their options commission-free!About MLNTQ
Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections.
CEOChristine Ann Miller, MBA
CEOChristine Ann Miller, MBA
Employees—
Employees—
HeadquartersParsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded2000
Founded2000
Employees—
Employees—
MLNTQ Key Statistics
Market cap1.51M
Market cap1.51M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume71.61K
Average volume71.61K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$8.60
52 Week high$8.60
52 Week low$0.06
52 Week low$0.06
Stock Snapshot
As of today, Melinta Therapeutics(MLNTQ) shares are valued at $0.11. The company's market cap stands at 1.51M.
Melinta Therapeutics(MLNTQ) stock opened on 2025-12-11 at —. The price climbed to — and dipped to —.
Melinta Therapeutics(MLNTQ) shares are trading with a volume of 0, against a daily average of 71.61K.
In the last year, Melinta Therapeutics(MLNTQ) shares hit a 52-week high of $8.60 and a 52-week low of $0.06.
In the last year, Melinta Therapeutics(MLNTQ) shares hit a 52-week high of $8.60 and a 52-week low of $0.06.